TCL Archive Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis December 30, 2011
TCL Archive Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation May 9, 2014
TCL Archive Options For Changes, Some Drastic, In Cooperative Groups Suggested By CTEP April 11, 1986
TCL Archive Cancer Webmasters Seek to Develop Tools for Greater Use of NCI Cancer Information May 5, 2000
